Coya Therapeutics Inc COYA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 4:00 PM EDT
8.15quote price arrow up+0.07 (+0.87%)
Volume
36,718
52 week range
3.21 - 10.69
Loading...
  • Open8.06
  • Day High8.48
  • Day Low8.06
  • Prev Close8.08
  • 52 Week High10.69
  • 52 Week High Date03/18/24
  • 52 Week Low3.21
  • 52 Week Low Date10/06/23

Key Stats

  • Market Cap119.138M
  • Shares Out14.62M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change11.34

KEY STATS

  • Open8.06
  • Day High8.48
  • Day Low8.06
  • Prev Close8.08
  • 52 Week High10.69
  • 52 Week High Date03/18/24
  • 52 Week Low3.21
  • 52 Week Low Date10/06/23
  • Market Cap119.138M
  • Shares Out14.62M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change11.34

RATIOS/PROFITABILITY

  • EPS (TTM)-0.82
  • P/E (TTM)-9.92
  • Fwd P/E (NTM)-9.59
  • EBITDA (TTM)-7.876M
  • ROE (TTM)-86.60%
  • Revenue (TTM)6.002M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-133.08%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Coya Therapeutics Inc

 

Profile

MORE
Coya Therapeutics, Inc. is a clinical-stage biotechnology company, which is engaged in developing treatments focused on the biology and potential therapeutic advantages of regulatory T cells (Tregs) to target systemic inflammation and neuroinflammation. Its initial developmental programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases of high unmet medical need. Its diversified candidate pipeline includes both ex vivo and in vivo...
Howard Berman Ph.D.
Chairman of the Board, President, Chief Executive Officer
Fred Grossman
President, Chief Medical Officer
David Snyder
Chief Financial Officer, Chief Operating Officer
Address
5850 San Felipe St., Suite 500
Houston, TX
77057
United States

Top Peers

SYMBOLLASTCHG%CHG
ARMP
Armata Pharmaceuticals Inc
2.92-0.29-9.03%
OMGA
Omega Therapeutics Inc
2.36UNCHUNCH
SYRS
Syros Pharmaceuticals Inc
5.43+0.37+7.31%
VXRT
Vaxart Inc
0.8647+0.0447+5.4512%
RZLT
Rezolute Inc
2.68-0.17-5.96%